Watch CBS News

FDA approves Alzheimer's drug Leqembi

The Food and Drug Administration on Thursday gave its approval to Leqembi, a drug designed to slow the progression of Alzheimer's disease. Leqembi is not considered a cure for Alzheimer’s, but will be covered by Medicare. Dr. Jon LaPook has more.
Jul 6, 2023 (02:14)
Videos
View CBS News In
CBS News App Open
Chrome Safari Continue